Patent · US Active

Nanoscale artificial antigen presenting cells

US10435668B2 · kind B2 · utility

1Cited by

12References

15Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Jonathan Schneck · Silver Spring, US
Mathias Oelke · Parkville, US
Karlo Perica · Baltimore, US

Key dates

Filing date	Mar 13, 2014
Grant date	Oct 8, 2019
Priority date	—
Expiry date	Aug 1, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides nano-scale Artificial Antigen Presenting Cells (aAPC), which deliver stimulatory signals to lymphocytes, including cytotoxic lymphocytes, for use as a powerful tool for immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.